Adaptimmune Therapeutics shares owned by Raymond James Financial
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Raymond James Financial
from 13F filings
Historical chart of Raymond James Financial investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Raymond James Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.3k | 25k | 0.13 |
| 2025-06-30 | $6.1k | 25k | 0.24 |
| 2025-03-31 | $5.0k | 25k | 0.20 |
| 2024-12-31 | $17k | 31k | 0.54 |